M Emmy M Dolman Selected Research

M Emmy M Dolman Research Topics

Disease

13	Neuroblastoma 01/2022 - 01/2014
12	Neoplasms (Cancer) 01/2022 - 01/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2021 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 05/2016
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Medulloblastoma 01/2022
1	Glioma (Gliomas) 01/2022
1	Rhabdoid Tumor (Rhabdoid Tumors) 01/2021
1	Leukemia 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2020
1	Carcinogenesis 05/2016
1	Retinoblastoma (Glioblastoma, Retinal) 11/2015
1	Ischemia 07/2014
1	Hypoxia (Hypoxemia) 07/2014
1	Renal Insufficiency (Renal Failure) 07/2014
1	Tics (Tic) 02/2014
1	Inflammation (Inflammations) 11/2012

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 10/2021 - 03/2015
3	Proteins (Proteins, Gene)FDA Link 05/2016 - 02/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
2	Apoptosis Regulatory ProteinsIBA 01/2021 - 05/2016
2	venetoclaxIBA 01/2021 - 05/2016
2	4- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA 11/2015 - 01/2014
1	pyrvinium (Vankin)FDA Link 05/2021
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2021
1	Adenine FDA LinkGeneric 01/2021
1	Biological ProductsIBA 01/2021
1	Cyclin D1IBA 01/2021
1	RG7388IBA 01/2021
1	CytosineIBA 01/2021
1	Gemcitabine FDA Link 11/2020
1	RNA (Ribonucleic Acid)IBA 11/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2020
1	olaparibIBA 09/2020
1	GSK-2816126IBA 01/2017
1	Histone MethyltransferasesIBA 01/2017
1	Lysine (L-Lysine)FDA Link 01/2017
1	Polycomb Repressive Complex 2IBA 01/2017
1	MethyltransferasesIBA 01/2017
1	Histones (Histone)IBA 01/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2015
1	Cyclin-Dependent Kinase 2IBA 11/2015
1	NucleophosminIBA 11/2015
1	dabrafenibIBA 03/2015
1	omipalisibIBA 03/2015
1	acetonitrileIBA 03/2015
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2015
1	2-(morpholin-4-yl)benzo(h)chromen-4-oneIBA 01/2015
1	DNA-Activated Protein KinaseIBA 01/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2015
1	AntioxidantsIBA 07/2014
1	Superoxides (Superoxide)IBA 07/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2014
1	8- (4- chloro- phenylthio)- 2'- O- methyladenosine- 3'- 5'- cyclic monophosphateIBA 07/2014
1	erythromycin propionate-N-acetylcysteinateIBA 07/2014
1	Cisplatin (Platino)FDA LinkGeneric 07/2014
1	Messenger RNA (mRNA)IBA 02/2014
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 02/2014
1	Serum-Free Culture MediaIBA 02/2014
1	rho-Associated KinasesIBA 11/2012

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2015
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
1	Radiotherapy 01/2022
1	Precision Medicine 11/2020
1	Aftercare (After-Treatment) 11/2015
1	Combined Modality Therapy 11/2015
1	Oral Administration 03/2015
1	Kidney Transplantation 11/2012